CD44 selectively associates with active Src family protein tyrosine kinases Lck and Fyn in glycosphingolipid-rich plasma membrane domains of human peripheral blood lymphocytes

Blood

Volumn 91, Issue 10, 1998, Pages 3901-3908

  Llangumaran, Subburaj ^a   Briol, Anne ^a   Hoessli, Daniel C ^a  

^a UNIVERSITY OF GENEVA MEDICAL SCHOOL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CELL SURFACE RECEPTOR; GLYCOSPHINGOLIPID; GLYCOSYLPHOSPHATIDYLINOSITOL; HERMES ANTIGEN; PROTEIN TYROSINE KINASE;

ARTICLE; B LYMPHOCYTE ACTIVATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; MACROPHAGE ACTIVATION; NATURAL KILLER CELL; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

EID: 0032525106     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v91.10.3901     Document Type: Article

References (64)

1. Lesley J, Hyman R, Kincade PW: CD44 and its interactions with extracellular matrix. Adv Irnmunol 54:271, 1993
2. Herrlich P, Zoller M, Pals ST, Ponta H: CD44 splice variants: Metastases meet lymphocytes. Immunol Today 14:395, 1993
3. Aruffo A, Stamenkovic I, Melnick M, Underhill CB, Seed B: CD44 is the principal cell surface receptor for hyaluronate. Cell 61:1303, 1990
4. Haynes BF, Telen MJ, Hale LP, Denning SM: CD44 - A molecule involved in leukocyte adherence and T-cell activation. Immunol Today 10:423, 1989
5. Underhill C: CD44: The hyaluronan receptor. J Cell Sci 103:293, 1992
6. Aruffo A: CD44: One ligand, two functions. J Clin Invest 98:2191, 1996
7. Huet S, Groux H, Caillou B, Valentin H, Prieur A-M, Bernard A: CD44 contributes to T cell activation. J Immunol 143:798, 1989
8. Simizu Y, van Seventer GA, Siringanian R, Wahl L, Shaw S: Dual role of CD44 molecule in T cell adhesion and activation. J Immunol 143:2457, 1989
9. Denning SM, Le PT, Singer KH, Haynes BF: Antibodies against the CD44 p80 lymphocyte homing receptor molecule augment human peripheral blood T cell activation. J Immunol 144:7, 1990
10. Conrad P, Rothman BL, Kelly KA, Blue M-L: Mechanism of peripheral T cell activation by coengagement of CD44 and CD2. J Immunol 149:1833, 1992
11. Pierres A, Lipcey C, Mawas C, Olive D: A unique monoclonal antibody identifies a new T cell activation pathway. Eur J Immunol 22:413, 1992
12. Galandrini R, Albi N, Tripodi G, Zarcone D, Terenzi A, Moretta A, Grossi CE, Velardi A: Antibodies to CD44 trigger effector functions of human T cell clones. J Immunol 150:4225, 1993
13. Seth A, Gote L, Nagarkatti M, Nagarkatti PS: T-cell-receptor-independent activation of cytolytic activity of cytotoxic T lymphocytes mediated through CD44 and gp90MEL-14. Proc Natl Acad Sci USA 88:7877, 1991
14. Pericle F, Sconocchia G, Titus JA, Segal DM: CD44 is a cytotoxic triggering molecule on human polymorphonuclear cells. J Immunol 157:4657, 1996
15. Tan PHS, Santos EB, Rossbach H-C, Sandmaier BM: Enhancement of natural killer activity by an antibody to CD44. J Immunol 150:812, 1993
16. Sconocchia G, Titus JA, Segal DM: CD44 is a cytotoxic triggering molecule in human peripheral blood NK cells. J Immunol 153:5473, 1994
17. Galandrini R, De Maria R, Piccoli M, Frati L, Santoni A: CD44 triggering enhances human NK cell cytotoxic functions. J Immunol 153:4399, 1994
18. Webb DSA, Shimizu Y, van Seventer GA, Shaw S, Gerrard TL: LFA-3, CD44, and CD45: Physiologic triggers of human monocyte TNF and IL-1 release. Science 249:1295, 1990
19. Bourguignon LYW, Lokeshwar VB, Chen X, Kerrick WG: Hyaluronic acid-induced lymphocyte signal transduction and HA receptor (GP85/CD44)-cytoskeleton interaction. J Immunol 151:6634, 1993
20. Galandrini R, Galluzzo E, Albi N, Grossi CE, Velardi A: Hyaluronate is costimulatory for human T cell effector functions and binds to CD44 on activated T cells. J Immunol 153:21, 1994
21. Noble P, Lake F, Henson P, Riches D: Hyaluronate activation of CD44 induces insulin-like growth factor expression by a tumor necrosis factor-α-dependent mechanism in murine macrophages. J Clin Invest 91:2368, 1993
22. Noble PW, McKee CM, Cowman M, Shin HS: Hyaluronan fragments activate an NF-KκB/I-κBα autoregulatory loop in murine macrophages. J Exp Med 183:2373, 1996
23. McKee CM, Penno MB, Cowman M, Burdick MD, Stricter RM, Bao C, Noble PW: Hyaluronan (HA) fragments induce chemokine gene expression in alveolar macrophages - The role of HA size and CD44. J Clin Invest 98:2403, 1996
24. McKee CM, Lowenstein CJ, Horton MR, Wu J, Bao C, Chin BY, Choi AMK, Noble PW: Hyaluronan fragments induce nitric-oxide synthase in murine macrophages through nuclear factor κB-dependent mechanism. J Biol Chem 272:8013, 1997
25. Rafi A, Nagarkatti M, Nagarkatti PS: Hyaluronate-CD44 interactions can induce murine B-cell activation. Blood 89:2901, 1997
26. Bjermer L, Lundgren R, Hallgren R: Hyaluronan and type III procollagen peptide concentrations in bronchoalveolar lavage fluid in idiopathic pulmonary fibrosis. Thorax 44:126, 1989
27. Poole A, Dieppe P: Biological markers in rheumatoid arthritis. Semin Arthritis Rheum 23S:17, 1994
28. Bartolazzi A, Peach R, Aruffo A, Stamenkovic I: Interaction between CD44 and hyaluronate is directly implicated in the regulation of tumor development. J Exp Med 180:53, 1994
29. West DC, Hampson IN, Arnold F, Kumar S: Angiogenesis induced by degradation products of hyaluronic acid. Science 228:1324, 1985
30. Taher TE, Smit L, Griffioen AW, Schilder Tol EJ, Borst J, Pals ST: Signaling through CD44 is mediated by tyrosine kinases. Association with p561ck in T lymphocytes. J Biol Chem 271:2863, 1996
31. Neame SJ, Uff CR, Sheikh H, Wheatley SC, Isacke CM: CD44 exhibits a cell type dependent interaction with triton X-100 insoluble, lipid rich, plasma membrane domains. J Cell Sci 108:3127, 1995
32. Perschl A, Lesley J, English N, Hyman R, Trowbridge IS: Transmembrane domain of CD44 is required for its detergent insolubility in fibroblasts. J Cell Sci 108:1033, 1995
33. Low MG: The glycosyl-phosphatidylinositol anchor of membrane proteins. Biochim Biophys Acta 988:427, 1989
34. Robinson PJ: Phosphatidylinositol membrane anchors and T-cell activation. Immunol Today 12:35, 1991
35. Stefanova I, Horejsi V, Ansotegui IJ, Knapp W, Stockinger H: GPI-anchored cell-surface molecules complexed to protein tyrosine kinases. Science 254:1016, 1991
36. Brown DA: The tyrosine kinase connection: How GPI-anchored proteins activate T cells. Curr Opin Immunol 5:349, 1993
37. Ilangumaran S, Briol A, Hoessli DC: Distinct interactions among GPI-anchored, transmembrane and membrane associated intracellular proteins, and sphingolipids in lymphocyte and endothelial cell plasma membranes. Biochim Biophys Acta Biomembranes 1328:227, 1997
38. Lisanti MP, Scherer PE, Vidugiriene J, Tang ZL, Hermanowski-Vosatka A, Tu YH, Cook RF, Sargiacomo M: Characterization of caveolin-rich membrane domains isolated from an endothelial-rich source: Implications for human disease. J Cell Biol 126:111, 1994
39. Simons K, Ikonen E: Functional membrane rafts in cell membranes. Nature 387:569, 1997
40. Brown DA, Rose JK: Sorting of GPI-anchored proteins to glycolipid-enriched membrane subdomains during transport to the apical cell surface. Cell 68:533, 1992
41. Kurzchalia TV, Hartmann E, Dupree P: Guilt by insolubility - Does a protein's detergent insolubility reflect caveolar location? Trends Cell Biol 5:187, 1995
42. Hunter T: Protein kinases and phosphatases: The Yin and yang of protein phosphorylation and signaling. Cell 80:225, 1995
43. Galandrini R, Piccoli M, Frati L, Santoni A: Tyrosine kinase-dependent activation of human NK cell functions upon triggering through CD44 receptor. Eur J Immunol 26:2807, 1996
44. Ohta S, Yoshida J, Iwata H, Hamaguchi M: Hyaluronate activates tyrosine phosphorylation of cellular proteins including focal adhesion kinase via CD44 in human glioma cells. Int J Oncol 10:561, 1997
45. Schraven B, Schirren A, Kirchgessner H, Siebert B, Meuer SC: A CD45/p561ck-associated phosphoproteins (pp29-pp32) undergo alterations in human T-cell activation. Eur J Immunol 22:1857, 1992
46. Ami S, Senaldi G, Poincelet M, Hoessli DC: Selective association of the p59fyn tyrosine kinase with murine T lymphoma membrane phosphoproteins. Oncogene 8:2485, 1993
47. Bourguignon LYW: Interactions between the membrane-cytoskeleton and CD44 during lymphocyte signal transduction and cell adhesion. Curr Top Membranes 43:293, 1996
48. Bourguignon LYW, Zhu H, Chu A, Iida N, Zhang L, Hung M-C: Interaction between the adhesion receptor, CD44, and the oncogene product, p185HER2, promotes human ovarian tumor cell activation. J Biol Chem 272:27913, 1997
49. Schroeder R, London E, Brown DA: Interactions between saturated acyl chains confer detergent resistance on lipids and glycosylphosphatidylinositol (GPI)-anchored proteins: GPI-anchored proteins in liposomes and cells show similar behavior. Proc Natl Acad Sci USA 91:12130, 1994
50. Spiegel S, Fishman PH, Weber RJ: Direct evidence that endogeneous GM1 gangliosides can mediate thymocyte proliferation. Science 230:1285, 1985
51. Gouy H, Debre P, Bismuth G: Triggering of a sustained calcium response through a p561ck-dependent pathway by exogenous ganglioside GM1 in human T lymphocytes. J Immunol 155:5160, 1995
52. Hakomori S-I, Igarashi Y: Gangliosides and glycosphingolipids as modulators of cell growth, adhesion, and transmembrane signalling. Adv Lipid Res 25:147, 1993
53. Massague J: Neurotrophic factors - Crossing receptor boundaries. Nature 382:29, 1996
54. Bohuslav J, Horejsi V, Hansmann C, Stockl J, Weidle UH, Majdic O, Bartke I, Knapp W, Stockinger H: Urokinase plasminogen activator receptor, beta 2-integrins, and Src-kinases within a single receptor complex of human monocytes. J Exp Med 181:1381, 1995
55. Petty HR, Todd RF: Integrins as promiscuous signal transduction devices. Immunol Today 17:209, 1996
56. Lisanti MP, Scherer PE, Tang ZL, Sargiacomo M: Caveolae, caveolin-rich membrane domains: A signalling hypothesis. Trends Cell Biol 4:231, 1994
57. Field KA, Holowka D, Baird B: Fc epsilon RI-mediated recruitment of p53/56(lyn) to detergent-resistant membrane domains accompanies cellular signaling. Proc Natl Acad Sci USA 92:9201, 1995
58. Field KA, Holowka D, Baird B: Compartmentalized activation of the high affinity immunoglobulin E receptor within membrane domains. J Biol Chem 272:4276, 1997
59. Fujimoto T, Nakade S, Miyawaki A, Mikoshiba K, Ogawa K: Localization of inositol 1,4,5-trisphosphate receptor-like protein in plasmalemmal caveolae. J Cell Biol 119:1507, 1992
60. Pike LJ, Casey L: Localization and turnover of phosphatidylinositol 4,5-bisphosphate in caveolin-enriched membrane domains. J Biol Chem 271:26453, 1996
61. Mikecz K, Brennan FR, Kim JH, Glant TT: Anti-CD44 treatment abrogates tissue oedema and leukocyte infiltration in murine arthritis. Nat Med 1:558, 1995
62. Verdrengh M, Holmdahl R, Tarkowski A: Administration of antibodies to hyaluronanreceptor (CD44) delays the start and ameliorates the severity of collagen II arthritis. Scand J Immunol 42:353, 1995
63. Liu DC, Sy MS: Phorbol myristate acetate stimulates the dimerization of CD44 involving a cysteine in the transmembrane domain. J Immunol 159:2702, 1997
64. Liu D, Sy MS: A cysteine residue located in the transmembrane domain of CD44 is important in binding of CD44 to hyaluronic acid. J Exp Med 183:1987, 1996